peginterferon alfa-2a

Trials studying peginterferon alfa-2a

• phase2DOC1021 Dendritic Cell Immunotherapy for Refractory Melanomarecruitingn=35
• phase3Nilotinib ± Peg-IFN for First Line Chronic Phase CML Patientscompletedn=200
• phase3Peg-interferon for Inactive Chronic Hepatitis B Carrierscompletedn=90
• phase4Study of the Efficacy and Safety of Pegnano Plus Barivir (Ribavirin) in Treatment-naïve Patients With Chronic Hepatitis C at KienGiang General Hospitalcompletedn=100
• phase2SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB).completedn=21
• phase2A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis Ccompletedn=30
• phase1A Study to Evaluate the Safety, Tolerability, Drug Levels, Food, Formulation, and pH Effects on Relative Absorption of BMS-986465 and Its Active Derivative BMS-986464 in Healthy Participantsterminatedn=267
• phase2Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)completedn=175